Active substance
Results for the substance papillomavirus vaccine type 6 11 16 18 31 33 45 52 58
2 results
About this active substance
The human papillomavirus (HPV) vaccine, which protects against types 6, 11, 16, 18, 31, 33, 45, 52, and 58, is used to prevent HPV infections and associated conditions, including genital warts and cancers of the cervix, vulva, vagina, anus, and oropharynx. This vaccine provides extended protection against high-risk HPV types responsible for the majority of cervical cancer cases.
The vaccine is administered intramuscularly, usually in three doses over a six-month period, and is recommended for both girls and boys starting at ages 9-12, before exposure to the virus.
Common side effects include pain at the injection site, mild fever, headache, and fatigue. In rare cases, severe allergic reactions may occur.
The HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52, and 58) is an essential measure for preventing HPV-associated cancers and other conditions, significantly contributing to reducing the burden of diseases caused by this virus.
The vaccine is administered intramuscularly, usually in three doses over a six-month period, and is recommended for both girls and boys starting at ages 9-12, before exposure to the virus.
Common side effects include pain at the injection site, mild fever, headache, and fatigue. In rare cases, severe allergic reactions may occur.
The HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52, and 58) is an essential measure for preventing HPV-associated cancers and other conditions, significantly contributing to reducing the burden of diseases caused by this virus.